Orei Health Named a Finalist in the 8th ING Grant Program

We are proud to announce that Orei Health has been selected as one of the finalists in the 8th edition of the ING Grant Program – a national initiative recognizing breakthrough technologies improving human health and wellbeing.

This distinction acknowledges our continued work at the intersection of medical science and technology, creating human-centered innovations that make preventive healthcare more accessible, data-driven, and connected.

Why this matters

The ING Grant Program, organized by ING Bank Śląski, aims to support and promote projects that respond to one of today’s most pressing challenges:
How can we use technology to improve health?

This year’s finalists represent a diverse landscape of health and biotechnology innovation – from AI-powered diagnostics to biosensors and laboratory automation tools – all united by a shared vision of transforming the future of healthcare.

Meet the Finalists of the 8th ING Grant Program

In this year’s edition of the ING Grant Program, the organizers searched for startups and researchers developing innovative solutions addressing the key question:
How can we use technology to improve health?

The final ten projects selected for 2025 represent some of the most promising directions in health technology, life sciences, and digital innovation:

  • Air Abrasion System – high-pressure dental device (AbraJet) enabling painless caries treatment
  • Bodyscope – robotic 360° full-body scanning system for early detection of skin diseases and cancer
  • DopaSense – pocket-sized biosensor detecting dopamine levels, making depression measurable
  • Labplus – AI-based application that automatically interprets laboratory test results into clear, personalized health insights
  • Living Networks – vascularized human tissue models for preclinical and functional diagnostics
  • Orei Health – advancing preventive care and telemedicine through intelligent, patient-friendly health technologies
  • Prometheus MedTech.AI – software that analyzes fetal and neonatal heart ultrasound recordings to automatically detect congenital heart defects
  • Smarter Diagnostics – intelligent diagnostic-analytics platform supporting clinicians, athletes, and active individuals
  • Syntro – automation platform for pharmaceutical companies streamlining regulatory document creation
  • TSM-AI (3sense.ai) – integrative data platform combining laboratory results, wearable data, and nutrition insights into one comprehensive view of health

We congratulate all finalists and look forward to meeting on December 1st in Warsaw for the final gala.

 

Orei Health’s perspective

At Orei Health, we are building solutions designed to empower people through technology and data — making health insights more proactive, personal, and evidence-based.


Being selected as part of this group confirms that innovation in healthcare is not only about devices or data, but about enabling better everyday care through empathy, precision, and trust.

"We hope that in the future, patients receiving a blood test referral will have a choice: go to a collection point or receive an approved kit for self-collection at home. This paradigm shift requires not only the mature technology we are developing, but also a new approach to diagnostics that places greater emphasis on patient convenience and the ability to conduct tests in a more flexible and individualized manner,"
Dawid Boreński
CEO and co-founder of Orei Health.